Opioids May Play Role in Cancer Growth

When Dr. Jonathan Moss was developing a drug to relieve the severe constipation plaguing end-stage cancer patients taking opioid painkillers, he noticed a few of those patients lived longer than expected. Although likely to die within a month, some "went on to live for five to six months," Moss said. He began to think the methylnaltrexone (Relistor) might be doing more than simply improving their ability to eat. "I began to wonder in my mind…could it be an effect on the progression of the...Full Story
Commenting on this article is closed.